Evidence map›Paper›PMID 22158621›Full record

ArticleThe Journal of biological chemistry2012

Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis.

Sanjay K Singh, Avinash Thirumalai, David J Hammond, Michael K Pangburn, Vinod K Mishra, David A Johnson, Antonio E Rusiñol, Alok Agrawal

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Evolution of C-Reactive Protein.Frontiers in immunology · 2019
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sanjay K SinghDepartment of Pharmacology, Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee 37614, USA.
Avinash Thirumalai
David J Hammond
Michael K Pangburn
Vinod K Mishra
David A Johnson
Antonio E Rusiñol
Alok Agrawal
East Tennessee State University · USUniversity of Alabama at Birmingham · USThe University of Texas Health Science Center at Tyler · US

Funding

Structure-Function Relationships of C-Reactive ProteinR01HL071233 · NHLBI · EAST TENNESSEE STATE UNIVERSITY · PI AGRAWAL, ALOK · 2002 to 2011
$2.6M
REGULATION OF COMPLEMENT BY MEMBRANE PROTEINSR01DK035081 · NIDDK · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI PANGBURN, MICHAEL K. · 1986 to 2011
$2.5M
Regulation of prelamin A levels by Zmpste24 in quiescenceR15HL091502 · NHLBI · EAST TENNESSEE STATE UNIVERSITY · PI RUSINOL, ANTONIO E, SINENSKY, MICHAEL S · 2008 to 2008
$213k
Human Cathepsin G: Expression, C-Terminal Processing and Dual SpecificityR15HL091770 · NHLBI · EAST TENNESSEE STATE UNIVERSITY · PI JOHNSON, DAVID ANDREW · 2007 to 2007
$210k
NHLBI NIH HHS 1R15HL091502NHLBI NIH HHS R01 HL071233NHLBI NIH HHS R01HL071233NHLBI NIH HHS R15 HL091502NHLBI NIH HHS R15 HL091770NHLBI NIH HHS R15HL091770NIDDK NIH HHS R01 DK035081NIDDK NIH HHS R01DK35081
6 · The paper itself

Abstract

C-reactive protein (CRP) is a cyclic pentameric protein whose major binding specificity, at physiological pH, is for substances bearing exposed phosphocholine moieties. Another pentameric form of CRP, which exists at acidic pH, displays binding activity for oxidized LDL (ox-LDL). The ox-LDL-binding site in CRP, which is hidden at physiological pH, is exposed by acidic pH-induced structural changes in pentameric CRP. The aim of this study was to expose the hidden ox-LDL-binding site of CRP by site-directed mutagenesis and to generate a CRP mutant that can bind to ox-LDL without the requirement of acidic pH. Mutation of Glu(42), an amino acid that participates in intersubunit interactions in the CRP pentamer and is buried, to Gln resulted in a CRP mutant (E42Q) that showed significant binding activity for ox-LDL at physiological pH. For maximal binding to ox-LDL, E42Q CRP required a pH much less acidic than that required by wild-type CRP. At any given pH, E42Q CRP was more efficient than wild-type CRP in binding to ox-LDL. Like wild-type CRP, E42Q CRP remained pentameric at acidic pH. Also, E42Q CRP was more efficient than wild-type CRP in binding to several other deposited, conformationally altered proteins. The E42Q CRP mutant provides a tool to investigate the functions of CRP in defined animal models of inflammatory diseases including atherosclerosis because wild-type CRP requires acidic pH to bind to deposited, conformationally altered proteins, including ox-LDL, and available animal models may not have sufficient acidosis or other possible modifiers of the pentameric structure of CRP at the sites of inflammation.

Indexed as

Mutagenesis, Site-DirectedPeptide MappingAmino Acid SubstitutionAnimalsBinding SitesCHO CellsC-Reactive ProteinCricetinaeCricetulusHumansHydrogen-Ion ConcentrationLipoproteins, LDLProtein BindingC-Reactive ProteinLipoproteins, LDLoxidized low density lipoprotein

Identifiers

PMID22158621
PMCPMC3271008
OpenAlexW2013205876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.